Literature DB >> 25832894

Potential factors associated with perceived cognitive impairment in breast cancer survivors.

Jamie S Myers1,2, Jo A Wick3, Jennifer Klemp4.   

Abstract

PURPOSE: This cross-sectional study was designed to explore potential factors associated with perceived cognitive impairment (PCI) in breast cancer survivors compared to controls and gain insight into perceived levels of severity for cognitive complaints.
METHODS: Women (N = 363, 317: breast cancer, 46: healthy controls) completed demographic questionnaire, MD Anderson Symptom Inventory, Attentional Function Index, and Functional Assessment for Cancer Therapy-Cognition. Group classification included pre-chemotherapy, current chemotherapy, and postchemotherapy (<1, >1- < 2, >2- < 5, >5 years).
RESULTS: A significant group effect was seen for PCI (F 6, 355 = 7.01, p < 0.0001). Controls reported less PCI than all other groups. Neuropathy was inversely correlated with PCI (r = -0.23; p < 0.0001) for participants with breast cancer. A significant association was demonstrated between exercise frequency and PCI in women exposed to chemotherapy (F 3, 135 = 3.78, p < 0.05). A multiple linear regression model built using forward selection methods explained 24 % of the variance (adjusted R (2)) for PCI in breast cancer participants and included group, body mass index (BMI), exercise, fatigue, and distress. Exercise frequency moderated the relationship between BMI and PCI for breast cancer participants (F 3, 198 = 2.4, p = 0.07) and reduced the negative effects of high BMI. The moderating effect of exercise was significant (F 3, 133 = 3.1, p = 0.03) when limited to participants exposed to chemotherapy.
CONCLUSIONS: PCI decreased for women >5 years postchemotherapy. Overweight survivors who exercised frequently reported less PCI than sedentary survivors. Study results provide support for a relationship between BMI and PCI in breast cancer survivors and exercise as a potential intervention for cognitive complaints. Further investigation of the influence of weight and exercise on cognitive function is warranted.

Entities:  

Keywords:  Breast cancer; Chemotherapy; Cognitive function; Exercise patterns; Neuropathy; Obesity

Mesh:

Year:  2015        PMID: 25832894      PMCID: PMC4586297          DOI: 10.1007/s00520-015-2708-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  45 in total

Review 1.  Chemotherapy and cognitive impairment: treatment options.

Authors:  J E Fardell; J Vardy; I N Johnston; G Winocur
Journal:  Clin Pharmacol Ther       Date:  2011-08-03       Impact factor: 6.875

2.  The Attentional Function Index--a self-report cognitive measure.

Authors:  Bernadine Cimprich; Moira Visovatti; David L Ronis
Journal:  Psychooncology       Date:  2011-02       Impact factor: 3.894

3.  Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.

Authors:  Vincent Koppelmans; Monique M B Breteler; Willem Boogerd; Caroline Seynaeve; Chad Gundy; Sanne B Schagen
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

4.  Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy.

Authors:  John D Merriman; Catherine Jansen; Theresa Koetters; Claudia West; Marylin Dodd; Kathryn Lee; Steven M Paul; Bradley E Aouizerat; Bruce A Cooper; Patrick S Swift; William Wara; Christine Miaskowski
Journal:  Oncol Nurs Forum       Date:  2010-07       Impact factor: 2.172

5.  Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI.

Authors:  A J Saykin; H A Wishart; L A Rabin; R B Santulli; L A Flashman; J D West; T L McHugh; A C Mamourian
Journal:  Neurology       Date:  2006-09-12       Impact factor: 9.910

6.  Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients.

Authors:  Lisa K Sprod; Supriya G Mohile; Wendy Demark-Wahnefried; Michelle C Janelsins; Luke J Peppone; Gary R Morrow; Raymond Lord; Howard Gross; Karen M Mustian
Journal:  J Geriatr Oncol       Date:  2012-01-27       Impact factor: 3.599

7.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

8.  Recruiting adaptive cellular stress responses for successful brain ageing.

Authors:  Alexis M Stranahan; Mark P Mattson
Journal:  Nat Rev Neurosci       Date:  2012-01-18       Impact factor: 34.870

9.  Weight gain during adjuvant and neoadjuvant chemotherapy for breast cancer: an audit of 100 women receiving FEC or CMF chemotherapy.

Authors:  K J Lankester; J E Phillips; P A Lawton
Journal:  Clin Oncol (R Coll Radiol)       Date:  2002-02       Impact factor: 4.126

10.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

Authors:  Joerg Dietrich; Ruolan Han; Yin Yang; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2006
View more
  26 in total

1.  Perceived cognitive function for breast cancer survivors: association of genetic and behaviorally related variables for inflammation.

Authors:  Jamie S Myers; Theresa A Koleck; Susan M Sereika; Yvette P Conley; Catherine M Bender
Journal:  Support Care Cancer       Date:  2017-03-01       Impact factor: 3.603

2.  Pupillary response: cognitive effort for breast cancer survivors.

Authors:  Jamie S Myers; Melike Kahya; Melissa Mitchell; Junqiang Dai; Jianghua He; Sanghee Moon; Kevin Hamilton; Mary Valla; Anne O'Dea; Jennifer Klemp; Monica Kurylo; Abiodun Akinwuntan; Hannes Devos
Journal:  Support Care Cancer       Date:  2018-08-10       Impact factor: 3.603

3.  Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer.

Authors:  Jennifer R Klemp; Jamie S Myers; Carol J Fabian; Bruce F Kimler; Qamar J Khan; Susan M Sereika; Annette L Stanton
Journal:  Support Care Cancer       Date:  2017-08-28       Impact factor: 3.603

4.  Modifiable and non-modifiable characteristics associated with sleep disturbance in oncology outpatients during chemotherapy.

Authors:  Sueann Mark; Janine Cataldo; Anand Dhruva; Steven M Paul; Lee-May Chen; Marilyn J Hammer; Jon D Levine; Fay Wright; Michelle Melisko; Kathryn Lee; Yvette P Conley; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2017-03-09       Impact factor: 3.603

5.  The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients.

Authors:  Jin-Hee Park; Yong Sik Jung; Young-Mi Jung; Sun Hyoung Bae
Journal:  Support Care Cancer       Date:  2018-11-29       Impact factor: 3.603

6.  Distinct attentional function profiles in older adults receiving cancer chemotherapy.

Authors:  Inger Utne; Borghild Løyland; Ellen Karine Grov; Hege Lund Rasmussen; Ann Helen Torstveit; Bruce A Cooper; Judy Mastick; Melissa Mazor; Melisa Wong; Steven M Paul; Yvette P Conley; Thierry Jahan; Christine Ritchie; Jon D Levine; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2018-08-22       Impact factor: 2.398

7.  Characteristics associated with inter-individual differences in the trajectories of self-reported attentional function in oncology outpatients receiving chemotherapy.

Authors:  Juliet Shih; Heather Leutwyler; Christine Ritchie; Steven M Paul; Jon D Levine; Bruce Cooper; Fay Wright; Yvette P Conley; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2016-10-20       Impact factor: 3.603

8.  Qigong intervention for breast cancer survivors with complaints of decreased cognitive function.

Authors:  Jamie S Myers; Melissa Mitchell; Susan Krigel; Andreanna Steinhoff; Alyssa Boyce-White; Karla Van Goethem; Mary Valla; Junqiang Dai; Jianghua He; Wen Liu; Susan M Sereika; Catherine M Bender
Journal:  Support Care Cancer       Date:  2018-08-21       Impact factor: 3.603

9.  Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment.

Authors:  Victoria J Bray; Haryana M Dhillon; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2018-05-04       Impact factor: 4.442

Review 10.  Advancing breast cancer survivorship among African-American women.

Authors:  Steven S Coughlin; Wonsuk Yoo; Mary S Whitehead; Selina A Smith
Journal:  Breast Cancer Res Treat       Date:  2015-08-25       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.